### ğŸ§  Popular Architectures Analyzed

**Convolutional Neural Networks (CNNs):**
- ResNet (18, 50, 152)
- DenseNet (121, 169)
- VGG (16, 19)
- InceptionV3
- EfficientNet (B0-B7)

**Transformer-Based Models:**
- Vision Transformers (ViT)
- BERT-based architectures
- MobileNet-v2 with ViT

**Hybrid Approaches:**
- CNN-LSTM combinations
- CNN-SVM integration
- Multi-stream networks
- cGAN-UNet

**Ensemble Methods:**
- Random Forest
- XGBoost
- Voting classifiers
- Multi-model ensembles

---

## ğŸ“ˆ Results

### ğŸ“Š Publication Trends

Our PRISMA-guided systematic review identified:

<div align="center">

| Metric | Count |
|--------|-------|
| **Initial Records** | 502 |
| **Records Screened** | 480 |
| **Full-Text Assessed** | 100 |
| **Studies Included** | **47** |
| **Time Period** | 2020-2025 |

</div>

### ğŸ“š Top Publishers

| Publisher | Studies | Percentage |
|-----------|---------|------------|
| **Elsevier** | 9 | 19.1% |
| **MDPI** | 5 | 10.6% |
| **Springer** | 4 | 8.5% |
| **RSNA** | 3 | 6.4% |
| **SPIE** | 3 | 6.4% |
| **IEEE** | 3 | 6.4% |
| **Others** | 20 | 42.6% |

### ğŸ“… Publication Year Distribution

| Year | Studies | Key Highlights |
|------|---------|----------------|
| **2015** | 5 | Early ML approaches (SVM, PCA) |
| **2016** | 3 | Deep Belief Networks emerge |
| **2017** | 4 | Transfer learning adoption |
| **2018** | 5 | CNN dominance begins |
| **2019** | 4 | XAI methods integration |
| **2020** | 2 | COVID-19 impact on publications |
| **2021** | 1 | Virtual conferences era |
| **2022** | 6 | **Peak year** - Multi-modal fusion |
| **2023** | 4 | Transformer models |
| **2024** | 5 | LLMs for radiology reports |
| **2025** | 5 | Multimodal learning, Clinical validation |

### ğŸ† Top Performing Models by Task

#### 1ï¸âƒ£ Binary Density Classification (Dense vs. Non-Dense)
ğŸ¥‡ **Mohamed et al. (2018)** [[1]](#ref1)
- **AUC**: 0.9882 (trained from scratch)
- **Approach**: CNN with custom architecture
- **Dataset**: 22,000 mammograms

#### 2ï¸âƒ£ Binary Cancer Detection (Benign vs. Malignant)
ğŸ¥‡ **Mahmood et al. (2024)** [[7]](#ref7)
- **Sensitivity**: 99%
- **AUC**: 0.99
- **Approach**: CNN+LSTM/SVM hybrid with Grad-CAM

#### 3ï¸âƒ£ Multi-Class BI-RADS Classification (A-D)
ğŸ¥‡ **Kate et al. (2022)** [[2]](#ref2)
- **Accuracy**: 97.98%
- **Approach**: InceptionV3 + GSA optimization + Kapur's entropy
- **Dataset**: DDSM

#### 4ï¸âƒ£ Dense Tissue Segmentation
ğŸ¥‡ **Saffari et al. (2020)** [[16]](#ref16)
- **Accuracy**: 98%
- **Dice Coefficient**: 0.88
- **Approach**: cGAN-UNet hybrid
- **Speed**: 7-8 images/second

---

## ğŸš§ Challenges & Future Directions

### âš ï¸ Current Challenges

| Challenge | Impact | Severity | Solutions Proposed |
|-----------|--------|----------|-------------------|
| **Dataset Bias** | Limited generalization across demographics | ğŸ”´ **Critical** | Multi-institutional collaboration |
| **Model Interpretability** | Low clinical trust and adoption | ğŸ”´ **Critical** | Enhanced XAI techniques |
| **External Validation** | Unclear real-world performance | ğŸ”´ **Critical** | Prospective multi-site trials |
| **Class Imbalance** | Poor minority class performance | ğŸŸ¡ **High** | Advanced augmentation, loss functions |
| **Computational Cost** | Limited accessibility in low-resource settings | ğŸŸ¡ **High** | Model compression, edge deployment |
| **Annotation Variability** | Inconsistent BI-RADS labeling | ğŸŸ¡ **High** | Consensus-based labeling |
| **Regulatory Approval** | Slow clinical adoption pathway | ğŸŸ¢ **Medium** | Standardized evaluation protocols |
| **Multimodal Integration** | Lack of fusion frameworks | ğŸŸ¢ **Medium** | Cross-modal learning architectures |

### ğŸ”® Future Research Directions

#### 1. ğŸ“Š Data & Benchmarking
- âœ¨ **Curated cross-site benchmarks** with standardized protocols
- âœ¨ **Diverse, representative datasets** spanning ethnicities, ages, scanner types
- âœ¨ **Bias audits** for fairness and equity assessment
- âœ¨ **Federated learning** for privacy-preserving multi-institutional training

#### 2. ğŸ¤– Model Development
- âœ¨ **Multimodal fusion architectures** (imaging + clinical + genomic)
- âœ¨ **Efficient models** for edge deployment and low-resource settings
- âœ¨ **Self-supervised learning** to reduce annotation burden
- âœ¨ **Foundation models** pre-trained on large-scale medical imaging

#### 3. ğŸ” Explainability & Trust
- âœ¨ **Enhanced XAI techniques** beyond heatmaps (counterfactuals, concept-based)
- âœ¨ **Clinician-friendly interfaces** with intuitive visualizations
- âœ¨ **Human-in-the-loop systems** for collaborative decision-making
- âœ¨ **Uncertainty quantification** for reliable confidence estimates

#### 4. ğŸ¥ Clinical Translation
- âœ¨ **Prospective clinical trials** with real-world validation
- âœ¨ **Workflow integration** with PACS, EHR systems
- âœ¨ **Regulatory pathways** (FDA, CE mark) compliance frameworks
- âœ¨ **Health economics studies** demonstrating cost-effectiveness

#### 5. ğŸŒ Global Impact
- âœ¨ **Low-resource adaptations** for developing countries
- âœ¨ **Multi-language support** for global accessibility
- âœ¨ **Teleradiology integration** for remote diagnostics
- âœ¨ **Open-source tools** for democratizing AI in breast cancer

---

## ğŸ“š Citations

### Main Paper

**This Systematic Review:**
```bibtex
